Brigham and Women's Hospital

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Brigham and Women's Hospital sits in the top decile of US sponsors by registered trial count (#35 of 15,742 sponsors by registered trial count).

937 total trials 145 currently recruiting 608 completed early-phase tilt top decile by trial count

Brigham and Women's Hospital: 937 sponsored US clinical trials, 145 recruiting.

Brigham and Women's Hospital sponsors 937 registered US clinical trials on ClinicalTrials.gov, 145 of them currently recruiting, and 608 completed. 124 of these trials are in Phase 3-4 (later-stage) and 197 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Type 2 Diabetes, with 13 trials.

Top-decile sponsor footprint

Brigham and Women's Hospital ranks in the top decile of sponsors by registered trial count (#35 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 64/100

608 of 677 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

937 total, page 11 of 19

COMPLETED Phase 2

Contrast Enhanced Ultrasonography to Detect Human Renal Transplant Rejection

NCT02733029

COMPLETED Phase 4

Gabapentin Regimens and Their Effects on Opioid Consumption

NCT03334903

COMPLETED Phase 1

Angiogenic Imaging in Pulmonary Arterial Hypertension

NCT03166306

COMPLETED Phase 2

Therapeutic Control of Aspirin-Exacerbated Respiratory Disease With Ifetroban

NCT03326063

TERMINATED NA

Virtual Visits at Brigham and Women's Hospital

NCT03592355

COMPLETED NA

Prediction of Outcomes Following Total Knee Replacement- Pilot

NCT04328701

COMPLETED NA

A Positive Psychology Intervention for Patients With Multiple Sclerosis

NCT03637699

COMPLETED NA

Interaction of Melatonin With MTNR1B Genotype on Glucose Control - Study 2

NCT03464084

COMPLETED NA

Potatoes, Hypertension RIsk and Endothelial Function Study

NCT03116919

COMPLETED NA

Comparing Different Types of Physical Therapy for Treating People With a Meniscal Tear and Osteoarthritis

NCT03059004

COMPLETED NA

Brief Title: Project 4 Example: Mixed Hybrid Checklist

NCT05272163

COMPLETED NA

Fetal Pillow Randomized Controlled Trial

NCT03342508

COMPLETED NA

Adapting Sleep and Yoga Interventions for Maximal Effectiveness in Low Income Populations

NCT03392194

COMPLETED Phase 1

DAW1033D in Obstructive Sleep Apnea

NCT03383887

COMPLETED NA

Supraclavicular Block vs Retroclavicular Block: Incidence of Phrenic Nerve Paralysis

NCT02631122

COMPLETED Phase 4

Patient Empowered Strategy to Reduce Asthma Morbidity in Highly Impacted Populations; PeRson EmPowered Asthma RElief

NCT02995733

TERMINATED Early Phase 1

Novel Strategies to Improve Immunomodulation and Non-invasive Clinical Monitoring in VCA

NCT03241719

COMPLETED NA

Excess Opioid Disposal Following Orthopedic Foot and Ankle Surgery

NCT03285061

COMPLETED NA

Hypoglycemia and Autonomic Nervous System Function- B2

NCT03422471

COMPLETED

Replication of the LEADER Diabetes Trial in Healthcare Claims

NCT03936049

COMPLETED

Replication of the ONTARGET Antihypertensive Trial in Healthcare Claims Data

NCT04354350

COMPLETED

Replication of the CARMELINA Diabetes Trial in Healthcare Claims

NCT03936036

COMPLETED

Replication of the TRANSCEND Antihypertensive Trial in Healthcare Claims Data

NCT04354376

COMPLETED

Replication of the SAVOR-TIMI Diabetes Trial in Healthcare Claims

NCT03936023

COMPLETED

Replication of the TECOS Diabetes Trial in Healthcare Claims

NCT03936062

COMPLETED

Replication of the CANVAS Diabetes Trial in Healthcare Claims

NCT03936010

COMPLETED Phase 1

DAW1033B2 in Obstructive Sleep Apnea

NCT03426631

COMPLETED NA

Somatotopic Configuration of Distal Residual Limb Tissues in Lower Extremity Amputations

NCT03374319

COMPLETED NA

Short-Term Endogenous Hydrogen Sulfide Upregulation

NCT03303534

COMPLETED Phase 2

Combined Upper-airway and Breathing Control Therapies for Obstructive Sleep Apnea

NCT03189173

TERMINATED NA

Rotational Thromboelastometry for the Transfusion Management of Postpartum Hemorrhage After Vaginal or Cesarean Delivery

NCT03064152

COMPLETED Phase 4

Safety and Cardiovascular Efficacy of Hydralazine and Isosorbide Dinitrate in Dialysis-Dependent ESRD

NCT02228408

COMPLETED NA

Enabling Personalized Medicine Through Exome Sequencing in the U.S. Air Force

NCT03276637

COMPLETED NA

Home-Based Exercise Program For Recovery After Transcatheter Aortic Valve Replacement

NCT02805309

COMPLETED NA

Motivational Interview Intervention to Help Patients Formulate Their Goals for Medical Care in the Emergency Department

NCT03208530

COMPLETED Phase 1

The ICON Study: Outcomes After FMT for Patients With IBD and CDI

NCT03106844

COMPLETED Phase 4

Menopausal Sleep Fragmentation and Body Fat Gain

NCT03047330

COMPLETED NA

Measurement of Renal Functional Reserve

NCT03190070

COMPLETED

Validation of Novel Predictive Score for Patients With Spinal Metastases

NCT03224650

COMPLETED NA

Acute Kidney Injury Standardized Clinical Assessment and Management Plan for Renal Replacement Initiation

NCT03368183

COMPLETED

Immune Profiling During Ocrelizumab Treatment in Multiple Sclerosis

NCT03138525

COMPLETED NA

Post-Acute Physician Home Visit Program

NCT03178513

COMPLETED NA

Pediatric Adenotonsillectomy Trial for Snoring

NCT02562040

COMPLETED NA

Hospital-Level Care at Home for Acutely Ill Adults

NCT03203759

COMPLETED NA

Spine Pain INtervention to Enhance Care Quality And Reduce Expenditure

NCT03083886

COMPLETED

Prediction of 30-Day Readmission Using Machine Learning

NCT04849312

COMPLETED Phase 4

Efficacy of Suvorexant in the Treatment of Hot Flash-associated Insomnia

NCT03034018

COMPLETED NA

Determine the Most Effective Intervention for Hemorrhage Control Readiness for Laypersons: The PATTS Trial

NCT03479112

COMPLETED NA

Informed Implementation of Breast Density Reporting

NCT02986360

COMPLETED

Preoperative Cognitive Screening in Older Spinal Surgical Patients

NCT02922634

← Previous Page 11 of 19 Next →

Phase Distribution

PhaseTrial count
Phase 1 90
Phase 2 107
Phase 3 47
Phase 4 77

What is open in the Brigham and Women's Hospital pipeline

145 recruiting of 937 indexed (15% open); 608 completed (65%).

Phase mix: 124 late (III/IV) vs 197 early (I/II) (early-phase heavy).

Top condition: Type 2 Diabetes (13 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Brigham and Women's Hospital: open-pipeline peers nationwide

Peers matched on 937 registered trials and 15% open enrollment, not the therapeutic-area sidebar.

Brigham and Women's Hospital sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 5%10%15%20% Total trials Recruiting share Brigham and Women's HospitalColumbia UniversityHoffmann-La RocheUniversity of MinnesotaUniversity of California, Los AngelesIncyte CorporationNorthwestern UniversityNationwide Children's HospitalUniversity of Michigan Rogel Cancer Center
Brigham and Women's Hospital sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Brigham and Women's Hospital sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 937 trials (± recruiting share)

Sponsors near 15% open enrollment (± trial volume)

What to do with this Brigham and Women's Hospital page

937 registered trials is a research-attention snapshot, not an endorsement of Brigham and Women's Hospital or any single study.

  • 145 of Brigham and Women's Hospital's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Type 2 Diabetes is the condition Brigham and Women's Hospital studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Type 2 Diabetes trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Brigham and Women's Hospital pipeline card: 937 registered trials from official public datasets.Report a data error.